IonMed BioWeld1tm System uses cold plasma for external closing of surgical and traumatic incisions. The technology enhances coagulation and generate instant closure concomitant with wound disinfection. The procedure seals the wound area completely, reduces infections, leaves minimal scarring, and can be done without special training in a shorter period of time.

Ionmed’s unique and innovative approach to skin closure combines the Bioweld1 system and with propriety medical plaster, Chitoplast, which both covers the wound and assists in approximating the incision edges ensuring proper wound closure.

IonMed is a graduate of Misgav Venture Accelerator and is currently funded by Crossroad and Trendlines Medical.